SCDM @SCDM_DataDriven

We’re using AI to make clinical development smarter. But are we smart about how we use AI? That’s the question Munenori Takata will explore at #SCDM25 — and it’s not just rhetorical. Generative AI is already reshaping how we diagnose, analyze, and manage #clinicaldata. But…

What happens in Baltimore shouldn’t stay in Baltimore. That’s why we’re excited to have @veevasystems as our Platinum Sponsor at #SCDM25 — helping us capture and share the conversations that matter most. From keynote insights to hallway debates, Veeva Systems is supporting the…

Still haven’t explored the Spring Issue of #JSCDM? It’s a reflection of where we are and where we’re heading. Grounded in #SCDM’s 2030 Vision. jscdm.org/issue/34/info/ @LaurenHouston_1 @TakuhiroBiostat

What’s next for Clinical Data Science? You tell us. Submit your session proposal for #EMEA26 and share your outlook on the course of the CDM industry. This year we're focusing on how tomorrow's trials will be shaped by: ✔️ How we connect fragmented data ✔️ Align…

Clinical trials don’t build themselves. Neither do bridges. At #EMEA26, we’re inviting you to help shape the future of #clinicaldata by submitting a session proposal that connects ideas, teams, and technologies. Whether you're working on smarter data flows, patient-centric…

Ever wondered what really happens inside an FDA submission review? Not just the forms and formats - but the metadata, the tools, the reviewer’s lens, and the evolving standards shaping tomorrow’s submissions. At #SCDM25, the pre-conference workshop “Data Requirements for an FDA…

Partnerships in Clinical Trials — a podcast series exploring the alliances that shape the future of #clinicalresearch. Hosted by Patrick Nadolny, 2024 SCDM Chair, each episode dives into the evolving relationships between key stakeholders: patient advocates, site…

Early phase trials are evolving. Are you? As trial designs grow more complex and data streams multiply, the traditional #CDM role is being stretched thin. At #SCDM25, Reema Deb, Terri Sampo, MPH, and Bo Zheng will explore how the Clinical Data Scientist is stepping in - not…

What do bridges and clinical trials have in common? At #EMEA26, we’re drawing inspiration from Copenhagen’s iconic Øresund Bridge - because just like cities, #clinicaltrials thrive when connections are strong. Connections between fragmented data. Between cross-functional teams.…

Ever been ghosted by your Gen Z CDM after 'slaying' the kickoff call? At #SCDM25, we’re diving into the generational dynamics reshaping clinical data teams. From quiet quitting to slaying deliverables - Gen Z is changing the game. But are we ready? Let's find at in Baltimore…

What does it take to design eCOA that works - for data managers, for patients, and for the future of #trials? As #eCOA becomes a central source of clinical trial data, the pressure to get it right is growing. This webinar brings together two experts who’ve worked across…

At #EMEA26, we’re not just talking about the future of clinical data science - we’re building it. And we want you to help shape the conversation. Whether you're a data visionary, a tech disruptor, or a champion of operational excellence, this is your chance to lead. Submit a…

Why is it essential to keep the GCDMP© up to date? Because it’s more than a guideline — it’s the standard that ensures #clinical #trial data is accurate, consistent, and credible. To maintain that standard, expert review is key. Right now, the chapter on “Design and…

In clinical trials, risk is inevitable. But how we manage it? That’s where transformation begins. At #SCDM25, we’re spotlighting a session that redefines what’s possible in Risk-Based Data Management (#RBDM). You'll discover: 🔍 How analytics can uncover hidden patterns before…

Quality In, Quality Out. But what happens in between? As eCOA adoption grows, it’s reshaping the #clinicaldata landscape - bringing new opportunities, but also new risks. While other systems have advanced, eCOA lags behind, leaving #DataManagers under pressure to clean, query,…

🌍 We're exactly 1 month away from the #SCDM Single Day Event in South Africa! On August 22, 2025, #SCDM returns to Bloemfontein under the theme “Data Management 2030: Embracing Innovation and Advancing Our Future” to explore what the future of clinical data looks like—and how…

Not all risks are created equal. So why do we treat them like they are? In clinical trials, risk management often feels like a checklist — long, exhaustive, and overwhelming. But what if we could flip the script? At #SCDM25, Christina Dinger will chair a session that challenges…

In clinical trials, quality isn’t something you check at the end. It’s something you build from the beginning. At #SCDM25, Preeti Kanyal will chair a session that explores how Quality by Design is reshaping Risk-Based CDM by aligning study setup, #data strategy, and endpoint…

RBQM has evolved—from pilots to platforms. But is the industry ready for 3.0? At #SCDM25, Abby Abraham leads a session exploring what’s driving the next wave of implementation: 🔎 ICH-E6(R3): Risk-based thinking as the new default 🔎 SLMs & Agentic AI: Smarter signal detection,…

Explore the #human and #strategic dimensions of risk-based quality management (RBQM) in a new podcast episode 🎧 In this sponsored episode, originally produced as part of @crscube's Clinical Data Talks podcast, Sylvain Berthelot, VP of Strategy and Marketing at @crscube welcomes…